AI assistant
ROOLIFE GROUP LTD — Director's Dealing 2021
Sep 26, 2021
65712_rns_2021-09-26_de126135-d311-4b91-9023-78cba2300372.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | RooLife Group Ltd |
|---|---|
| ABN | 14 613 410 398 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| We (the entity) give ASX the followingthe director for the purposes of section | information under listing rule 3.19A.2 and as agent for205G of the Corporations Act. |
|---|---|
| Name of Director | Bryan Carr |
| Date of last notice | 1 March 2021 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct interest |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. | Bryan Edward Carr ATF Shabaz Family Trust (MrCarr is a beneficiary of this trust) |
| Date of change | -21 September (200,000 Shares)-23 September (200,000 Shares)-24 September (100,000 Shares) |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | 12,250,000 Fully Paid Ordinary Shares.1,642,857 listed Options exercisable at $0.05 on or before31 October 202112,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject tothe following vesting conditions:-3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company’s Shares is equal to or greater than$0.055 per share.--3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company’s Shares is equal to or greater than$0.08 per share.--4,800,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company’s Shares is equal to or greater than$0.12 per share.All Executive Officer Options also have a time-basedvestingcondition of 5 February2023. |
|---|---|
| Class | Fully Paid Ordinary Shares |
| Number acquired | 500,000 Fully Paid Ordinary Shares |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | 410,000 Shares at $0.021 Per Share90,000 Shares at $0.023 Per Shares |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | 12,750,000 Fully Paid Ordinary Shares.1,642,857 listed Options exercisable at $0.05 on or before31 October 202112,000,000 Executive Officer Options expiring 5 February2024 with an exercise price of $0.055 subject tothe following vesting conditions:-3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2021, the VWAP ofthe Company’s Shares is equal to or greater than$0.055 per share.--3,600,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2022, the VWAP ofthe Company’s Shares is equal to or greater than$0.08 per share.--4,800,000: Vesting Condition will be taken to havebeen met if, for any consecutive trading day periodbetween the date of the grant of the ExecutiveOfficer Options and 5 February 2023, the VWAP ofthe Company’s Shares is equal to or greater than$0.12 per share.-All Executive Officer Options also have a time-basedvesting condition of 5 February 2023. |
|---|---|
| Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back | On-Market Trade |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y Change of Director’s Interest Notice
| Date of change | N/A |
|---|---|
| No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to whichthe interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation | N/A |
| Interest after change | N/A |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? | No |
| If so, was prior written clearance provided to allow the trade to proceed duringthis period? | N/A |
| If prior written clearance was provided, on what date was this provided? | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 4
01/01/2011